Skip to main navigation menu Skip to main content Skip to site footer

Research Articles

Early Access

Bioactive phytochemical extraction and characterisation from Solanum nigrum: an investigation of antirabies compounds using an in silico approach

DOI
https://doi.org/10.14719/pst.16217
Submitted
19 June 2026
Published
19-11-2026

Abstract

The present study includes the phytochemical evaluation of Solanum nigrum methanol extract; 1.64 % (0.82 g), revealing an 80 % positive detection rate for major phytochemical tests. The column-eluted fractions obtained by methanol and hexane solvents were efficient in separating the compounds with a ratio of 3 : 7 and 2 : 8 respectively. The gas chromatography mass spectrometry study of the collected fractions showed the presence of 19 different compounds from a total of 30 peaks. Major compounds identified included 3,3-dimethylpiperidine, 3-methylhexan-2-amine, N-dl-Alanylglycine, (S)-(+)-1-cyclohexylethylamine, tetratriacontane, lauramide, piperazine, amino acids and their derivatives. A bioassay of the extract for 2,2-diphenyl-2-picryl hydrazyl scavenging showed concentration-dependent activity, recording a maximum of 68.041 % and anti-inflammatory activity of 67.4 % at 100 µg/mL. The 3D structural study of the targeted rabies virus glycoprotein revealed that the G-chain contained a cavity volume of 65.4 ų without any tunnels, implying a low transportability function. Chain A was found to have a relatively high pocket volume of 565.1 ų along with one or several tunnels, which indicates the existence of significant ligand binding sites. Docking against G-chain revealed that N-dl-Alanylglycine had the highest binding affinity with a docking score of −4.86 kcal/mol. On the other hand, docking against Chain A indicated that lauramide is the most effective compound among the two, with a docking score of −5.583 kcal/mol. The binding affinities of the selected molecules revealed that both could inhibit the binding capacity of the virus during infection. The current results indicate that the selection of candidates and the hypothesis supporting the effectiveness of phytocompounds against rabies might require additional exploration through in vivo research.

References

  1. 1. Admasu P, Deressa A, Mengistu A, Gebrewold G, Fayera T. In vivo antirabies activity evaluation of hydroethanolic extract of roots and leaves of Phytolacca dodecandra. Glob Vet. 2014;12(1):12–8. https://doi.org/10.5829/idosi.gv.2014.12.01.81150
  2. 2. World Health Organisation. Regional strategy for traditional medicine in the Western Pacific. Geneva: World Health Organisation; 2002.
  3. 3. Takayama N. Rabies: a preventable but incurable disease. J Infect Chemother. 2008;14(1):8–14. https://doi.org/10.1007/s10156-007-0573-0
  4. 4. Tahmasbi SF, Revell MA, Tahmasebi N. Herbal medication to enhance or modulate viral infections. Nurs Clin North Am. 2021;56(1):79–89. https://doi.org/10.1016/j.cnur.2020.10.007
  5. 5. Xiang L, Wang Y, Yi X, He X. Anti-inflammatory steroidal glycosides from the berries of Solanum nigrum L. (European black nightshade). Phytochemistry. 2018;148:87–96. https://doi.org/10.1016/j.phytochem.2018.01.019
  6. 6. Kaunda JS, Zhang YJ. The genus Solanum: an ethnopharmacological, phytochemical and biological properties review. Nat Prod Bioprospect. 2019;9(2):77–137. https://doi.org/10.1007/s13659-019-0201-6
  7. 7. Yang MY, Hung CH, Chang CH, Tseng TH, Wang CJ. Solanum nigrum suppress angiogenesis-mediated tumour growth through inhibition of the AKT/mTOR pathway. Am J Chin Med. 2016;44(6):1273–88. https://doi.org/10.1142/S0192415X16500713
  8. 8. Ye LF, Gao ZW. Study of Solanum nigrum n-butanol extract on the proliferation of human colorectal cancer SW480 and its mechanism. World J Integr Tradit West Med. 2019;14(3):356–8. https://doi.org/10.13935/j.cnki.sjzx.190315
  9. 9. Saranya P, Aarthi TS, Kalaivani D. Phytochemical analysis and pharmacological properties of Solanum melongena (L.) peel extracts: a potential source of natural therapeutic agents. Vegetos. 2025. https://doi.org/10.1007/s42535-025-01423-7
  10. 10. Meyer RS, Whitaker BD, Little DP, Wu SB, Kennelly EJ, Long CL, et al. Parallel reductions in phenolic constituents resulting from the domestication of eggplant. Phytochemistry. 2015;115:194–206. https://doi.org/10.1016/j.phytochem.2015.02.006
  11. 11. Tunwagun DA, Akinyemi OA, Ayoade TE, Oyelere SF. Qualitative analysis of the phytochemical contents of different anatomical parts of ripe Solanum aethiopicum Linneaus fruits. J Complement Altern Med Res. 2020;9(3):14–22. https://doi.org/10.9734/jocamr/2020/v9i330142
  12. 12. Campisi A, Acquaviva R, Raciti G, Duro A, Rizzo M, Santagati NA. Antioxidant activities of Solanum nigrum L. leaf extracts determined in in vitro cellular models. Foods. 2019;8(2):63. https://doi.org/10.3390/foods8020063
  13. 13. Rahman H, Rahman N, Haris M, Mahmood R. Antioxidant and anti-inflammatory potentials of Solanum pubescens Willd an ethnomedicinal plant of South Western Andhra Pradesh, India. J Res Pharm. 2025;23(2):187–97.
  14. 14. Tomar NR, Singh V, Marla SS, Chandra R, Kumar R, Kumar A. Molecular docking studies with rabies virus glycoprotein to design viral therapeutics. Indian J Pharm Sci. 2010;72(4):486–90. https://doi.org/10.4103/0250-474X.73905
  15. 15. Jamal A, Nawaz A, Arif A, Shahid MN. Phytochemical and pharmacological potential of Solanum nigrum: a concise review. Acta Biol Slov. 2025;68(3):142–60. https://doi.org/10.14720/abs.68.3.20074
  16. 16. Roshan K, Mona K, Rupali H, Milind U. A review of the phytochemistry and pharmacological activities of Solanaceae family. Int J Pharm Chem Res. 2020;2(1):13–9. https://doi.org/10.33545/2664763X.2020.v2.i1a.15
  17. 17. Royani A, Mujawar NM, Hanafi M, Verma C, Lotulung PDN, Prastya ME, et al. Effect of solvent polarity on yield extract, antioxidant and antibacterial activities of phytochemicals from Andrographis paniculata leaves. Indian Chem Eng. 2025;67(1):1–15. https://doi.org/10.1080/00194506.2024.2409260
  18. 18. Zych M, Pyka-Pająk A. TLC in the analysis of plant material. Processes. 2025;13(11):3497. https://doi.org/10.3390/pr13113497
  19. 19. Sivakamasundari R, Mariajancyrani J, Chandramohan G. GC-MS analysis of chloroform extract of Solanum nigrum leaf. Sch Acad J Pharm. 2013;2(3):268–73. https://doi.org/10.36347/sajp
  20. 20. Rahman Lefta H. Biological activity of extract Solanum nigrum on some biological aspects of the blue fly Chrysomya albiceps (Diptera: Calliphoridae). Arch Razi Inst. 2022;77(3):1157–64. https://doi.org/10.22092/ARI.2022.357401.2038
  21. 21. Kulhade A, Shrivastava K. Identification of phytochemical compounds and their associated medicinal properties in Solanum nigrum fruit extract using gas chromatography–mass spectrometry. Libr Prog. 2024;44(6):603–10.
  22. 22. Sivaraj C, Yamini S, Yahavi A, Kumar RP, Arumugam P, Manimaaran A. Antioxidant, antimicrobial activities and GC-MS analysis of fruit extract of Solanum nigrum L. J Pharmacogn Phytochem. 2020;9(4):1114–21.
  23. 23. Zaidi SK, Ansari SA, Tabrez S, Naseer MI, Shahwan MJ, Banu N, et al. Antioxidant potential of Solanum nigrum aqueous leaves extract in modulating restraint stress-induced changes in rat's liver. J Pharm Bioallied Sci. 2019;11(1):60–8.https://doi.org/10.4103/jpbs.JPBS_58_18
  24. 24. Chen X, Dai X, Liu Y, Yang Y, Yuan L, He X, et al. Solanum nigrum Linn.: an insight into current research on traditional uses, phytochemistry and pharmacology. Front Pharmacol. 2022;13:918071. https://doi.org/10.3389/fphar.2022.918071
  25. 25. Yang F, Lin S, Ye F, Yang J, Qi J, Chen Z, et al. Structural analysis of rabies virus glycoprotein reveals pH-dependent conformational changes and interactions with a neutralizing antibody. Cell Host Microbe. 2020;27(3):441–53.e7. https://doi.org/10.1016/j.chom.2019.12.012
  26. 26. Hellert J, Buchrieser J, Larrous F, Minola A, de Melo GD, Soriaga L, et al. Structure of the prefusion-locking broadly neutralising antibody RVC20 bound to the rabies virus glycoprotein. Nat Commun. 2020;11(1):596. https://doi.org/10.1038/s41467-020-14398-7
  27. 27. Kokh DB, Amaral M, Bomke J, Grädler U, Musil D, Buchstaller HP, et al. Estimation of drug-target residence times by τ-random acceleration molecular dynamics simulations. J Chem Theory Comput. 2018;14(7):3859–69. https://doi.org/10.1021/acs.jctc.8b00230
  28. 28. Jabeen J, Ahmed N, Shahzad Z, Shahid M, Ahmad T. Insights for future pharmacology: exploring phytochemicals as potential inhibitors targeting SARS-CoV-2 papain-like protease. Future Pharmacol. 2024;4(3):510–40.https://doi.org/10.3390/futurepharmacol4030029
  29. 29. Hamran S, Al-Rajhi AA, Jasim K, Al-Theyab MA, Elahtam M, Al-Hail MK, et al. Efficacy and safety of adding ribavirin to sofosbuvir-based direct-acting antivirals (DAAs) in re-treating non-genotype 1 hepatitis C—a systematic review and meta-analysis. Diseases. 2025;13(5):138. https://doi.org/10.3390/diseases13050138
  30. 30. Lu Y, Cheng L, Liu J. Optimisation of inhibitory peptides targeting phosphoprotein of rabies virus. Int J Pept Res Ther. 2020;26(2):1043–9. https://doi.org/10.1007/s10989-019-09906-3
  31. 31. Li H, Habib O, Usman M, Usmani SA, Shafiq A, Akbar R, et al. In silico drug design targeting the rabies virus glycoprotein: phytochemicals as promising drug candidates. ChemistrySelect.2025;10(46). https://doi.org/10.1002/slct.202504329
  32. 32. Oranu EC, Ezeagha CC, Madueke AJ, Otarigho BE, Orjiakor J, Etuka IK. Molecular docking and virtual screening of Boswellia dalzielii phytochemicals as potential inhibitors of Rabies lyssavirus. GSC Biol Pharm Sci. 2025;33(2):267–79. https://doi.org/10.30574/gscbps.2025.33.2.0447

Downloads

Download data is not yet available.